The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

A new study from Cedars-Sinai Cancer has revealed that doctors often misjudge the stage of early pancreatic cancer, with ...

Pancreatic cancer (PC) remains one of the most lethal cancers worldwide, with only 13% of patients surviving more than five ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

Fractyl Health, Inc. announced promising preclinical data for its Rejuva Smart GLP-1 pancreatic gene therapy at the American Diabetes Association’s Scientific Sessions, revealing that a single ...

Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors account for this.

Pancreatic cancer is deadly; only about 10% of patients live over five years after they are diagnosed. Patients can be treated in several ways, including with chemotherapy and surgery. Immunotherapies ...

CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study.

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.

Researchers have developed a fetal pancreas organoid that contains the three key cell types in the pancreas for the first time.